Searched for
RATAN TATA CANCER TREATMENT
Cancer Weekly Horoscope (15th June - 21st June 2026): A Quiet Decision This Week Could Shape Your Future SuccessCancer Weekly Horoscope (15th June 2026 to 21st June 2026): This weekly horoscope indicates a meaningful and transformative week. The Moon ...- Tata Trusts vice chairman seeks inquiry into 1989 share transfer of Tata SonsA controversy surrounds a 1989 Tata Sons share transfer. Tata Trusts vice chairman Vijay Singh has requested an independent inquiry. This f...
- Weekly Horoscope for ♋ CANCER (June 13 - June 19, 2026): Trust Your Instincts, They Are Leading You in the Right DirectionCancer Weekly Horoscope (13th June 2026 to 19th June 2026): Cancer, this week brings emotional balance, deeper self-awareness, and a strong...
- India raises price cap on cancer drugs to tackle shortageIndia's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...
- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
- India's healthcare transformed in 12 years under PM Modi: ReportIndia's healthcare sector has seen a major transformation over the last 12 years. Health insurance coverage has expanded significantly. Mat...
- $10. 6 billion deal: GSK to buy US cancer specialist NuvalentBritish pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...
- Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
- A Tata Trust board meets amid shadows over old share dealSir Dorabji Tata Trust trustees met Monday for routine matters. A petition questioning a 1989 Tata Sons share transfer to Noel Tata's fathe...
- Are Tiger Woods and Vanessa Trump on the Verge of Breakup? Here's What Reports SayRecent reports suggest that Tiger Woods and Vanessa Trump are not on the verge of a breakup despite facing major personal challenges. Woods...
- West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.
- Texas big medical boost: Nvidia billionaire Tench Coxe, wife Simone donate $100 million to UT Austin healthcare projectNvidia board member Tench Coxe and his wife Simone Coxe have donated $100 million for a new medical center in Austin, Texas. This significa...
- Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, othersThe Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...
- This blood test may reveal lung cancer risk long before symptomsA new blood test can predict lung cancer more than five years before diagnosis. This breakthrough offers hope for early detection in India....
- Tata Trusts row: Fresh complaint filed with Charity Commissioner over share transferA fresh complaint has been filed with the Maharashtra Charity Commissioner ahead of the June 8 meeting of trustees of Sir Dorabji Tata Trus...
- Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
Load More
